Join ERDERA’s extended webinar on the Joint Transnational Call on 14 January

blank

Following the success of our previous session, ERDERA warmly invites researchers, patient advocates, and early-career professionals to an extended webinar on 14 January 2025. This webinar is part of the 2025 Joint Transnational Call for Proposals, “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”, which was officially launched on 10 December 2024.

Clickhere to register for the webinar.

This Webinar will:

  • Inform applicants about lessons learned about the evaluation.
  • Guide applicants with key translational, regulatory, data managing, and methodological considerations for drafting strong pre-proposals.
  • Address your questions through dedicated Q&A sessions.

Agenda (CET)

  • 14.00-14.10 Introduction (Ralph Schuster)
  • 14.10-14.20 Lessons learned from previous callsevaluators perspective
    (ChristineKinnon)
  • 14.20-14.30 Q&A Round 1
  • 14.30-14.45 Innovating Management Toolbox (IMT) and Mentoring service (Agustin Arasanz Duque, Rosan Kreeftmeijer-Vegter, Toni Andreu)
  • 14.45-15.00 Regulatory Support Service (Viviana Giannuzzi, David Morrow)
  • 15.00-15.10 Q&A Round 2
  • 15.10-15.25 Methodological Support (Rima Nabbout)
  • 15.25-15.40 Data standards and FAIRification (Marco Roos)
  • 15.40-15.50 Q&A Round 3
  • 15.50-16.00 Closing remarks  

Registration is mandatory

  • The registration deadline is14 January 2025.
  • Upon submitting your registration, you will receive connection links and calendar invitations to ensure seamless participation.

Note:The webinar will be recorded, and the video recording will be made availableexclusively to registered participants.

Don’t miss this chance to get ahead in the application process and ensure that your project stands out!

Find out more details about ERDERA’s Joint Transnational Call 2025 – Announcementhere.

News & Updates

You might also be interested in

Two expert‑led facilitation windows linked to EJPRD‑developed MOOCs, give learners the opportunity to engage directly with specialists in health data governance and translational research for rare diseases.
The two-day event will focus on translating research and policy initiatives into tangible benefits for Rare Disease patients through better prevention, diagnosis, and treatment.
Drawing on Europe-wide patient and carer surveys, ERDERA highlights how gender can shape diagnostic delays, care burden and the evidence base for rare-disease research.
European Parliament research service assessment, published in February 2026, identifies 31 measures that could form an EU rare disease action plan, highlighting European Reference Networks and cross-border collaboration including ERDERA as drivers of EU added value.